A detailed history of Clari Vest Asset Management LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Clari Vest Asset Management LLC holds 15,334 shares of IMVT stock, worth $421,838. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,334
Previous 15,334 -0.0%
Holding current value
$421,838
Previous $404,000 4.21%
% of portfolio
0.04%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$25.1 - $31.61 $727 - $916
-29 Reduced 0.19%
15,334 $404,000
Q1 2024

May 06, 2024

BUY
$30.27 - $43.79 $484 - $700
16 Added 0.1%
15,363 $496,000
Q4 2023

Feb 13, 2024

SELL
$31.31 - $44.19 $188,799 - $266,465
-6,030 Reduced 28.21%
15,347 $646,000
Q2 2023

Aug 14, 2023

SELL
$14.2 - $23.75 $22,720 - $38,000
-1,600 Reduced 6.96%
21,377 $405,000
Q1 2023

May 08, 2023

BUY
$15.27 - $19.72 $350,858 - $453,106
22,977 New
22,977 $356,000

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.